RxDoctor Payments Data

Oscar Lindo, MD

Family Medicine · Weeki Wachee, FLNPI 1841213071

Payments from drug & device makers

$591in general payments, 2019–2025

Across 31 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$117
  • Boehringer Ingelheim$85
  • GSK$71
  • Pfizer$61
  • Johnson & Johnson$57
  • Bayer$30
  • plus $169 from 9 others

What the payments were for

  • Food & beverage$591100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$591 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$36,975
Medicare patients
121
Services billed
492

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban157$159,723
Trelegy ElliptaFluticasone/Umeclidin/Vilanter118$98,475
JardianceEmpagliflozin44$55,082
FarxigaDapagliflozin Propanediol28$33,866
Breo ElliptaFluticasone/Vilanterol61$28,799
TradjentaLinagliptin18$26,549
OzempicSemaglutide27$25,117
XareltoRivaroxaban26$23,732
JanuviaSitagliptin Phosphate14$18,111
Ondansetron Hcl47$14,537
TrulicityDulaglutide15$14,194
Dabigatran EtexilateDabigatran Etexilate Mesylate37$11,360
Gabapentin474$11,240
Levothyroxine Sodium844$9,640
Atorvastatin Calcium757$7,114

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$61$159,723157 claims
GSKTrelegy Ellipta, Breo Ellipta$71$127,273179 claims
Boehringer IngelheimJardiance, Tradjenta$85$81,63062 claims
AstraZenecaFarxiga, Symbicort$117$38,22147 claims
Novo NordiskOzempic$18$25,11727 claims
Johnson & JohnsonXarelto$57$23,73226 claims
MerckJanuvia$16$18,11114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Weeki Wachee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →